XML 40 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statement of Cash Flows (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Operating activities:    
Net income attributable to the controlling and noncontrolling interests $ 3,071,000,000 $ 811,000,000
Less: Income from discontinued operations, net of income taxes (Note 5) (2,197,000,000) (189,000,000)
Income from continuing operations 874,000,000 622,000,000
Adjustments to reconcile net income to cash from operations:    
Depreciation and amortization 350,000,000 315,000,000
Pension expense (Note 13) 72,000,000 110,000,000
Canadian pension settlement charge (Note 13) 18,000,000 0
Restructuring provision (Note 8) 98,000,000 208,000,000
Environmental remediation charges (Note 19) 101,000,000 159,000,000
Stock-based compensation expense 59,000,000 53,000,000
Deferred income taxes (63,000,000) (127,000,000)
Equity affiliate losses (earnings), net of dividends 9,000,000 (8,000,000)
Asbestos settlement, net of tax 6,000,000 6,000,000
Pension cash contributions (47,000,000) (58,000,000)
Restructuring cash spending (Note 8) (56,000,000) (63,000,000)
Other 71,000,000 (84,000,000)
Change in certain asset and liability accounts:    
Receivables (302,000,000) (225,000,000)
Inventories (12,000,000) (83,000,000)
Other current assets (25,000,000) (3,000,000)
Accounts payable and accrued liabilities 166,000,000 49,000,000
Noncurrent assets (31,000,000) (9,000,000)
Noncurrent liabilities (69,000,000) (36,000,000)
Income taxes payable and interest payable 59,000,000 40,000,000
Cash from operating activities - Continuing Operations 1,278,000,000 866,000,000
Cash from operating activities - Discontinued Operations 4,000,000 173,000,000
Cash from operating activities 1,282,000,000 1,039,000,000
Capital spending:    
Additions to property, plant and equipment, and long-term investments (259,000,000) (193,000,000)
Proceeds from sale of assets 0 29,000,000
Business acquisitions, net of cash balances acquired (Note 4) (978,000,000) (53,000,000)
Proceeds from separation and merger of commodity chemicals business, net (Note 5) 940,000,000 0
Purchase of short-term investments (1,063,000,000) (730,000,000)
Proceeds from maturity of short-term investments 1,532,000,000 120,000,000
Payments on cross currency swap contracts (5,000,000) (23,000,000)
Payments for (Proceeds from) Other Investing Activities 2,000,000 6,000,000
Cash from (used for) investing activities - Continuing Operations 169,000,000 (844,000,000)
Cash used for investing activities - Discontinued Operations (1,000,000) (32,000,000)
Cash from (used for) investing activities 168,000,000 (876,000,000)
Debt:    
Net payments on short-term debt (13,000,000) (8,000,000)
Proceeds from debt issuance (Note 9) 1,000,000 397,000,000
Payment of debt (Note 9) (607,000,000) (202,000,000)
Settlement of forward starting swaps 0 (121,000,000)
Proceeds from termination of swaps 0 29,000,000
Issuance of treasury stock (Note 14) 59,000,000 110,000,000
Purchase of treasury stock (Note 14) (320,000,000) (92,000,000)
Dividends paid (Note 14) (259,000,000) (267,000,000)
Dividends paid on subsidiary common stock to noncontrolling interests (Note 14) (58,000,000) (61,000,000)
Other 10,000,000 (13,000,000)
Cash used for financing activities - Continuing Operations (1,187,000,000) (228,000,000)
Cash used for financing activities - Discontinued Operations 0 (13,000,000)
Cash used for financing activities (1,187,000,000) (241,000,000)
Effect of currency exchange rate changes on cash and cash equivalents (7,000,000) 13,000,000
Net increase/(decrease) in cash and cash equivalents 256,000,000 (65,000,000)
Cash and cash equivalents, beginning of period 1,306,000,000 1,457,000,000
Cash and cash equivalents, end of period 1,562,000,000 1,392,000,000
Interest paid, net of amount capitalized 166,000,000 178,000,000
Taxes paid, net of refunds $ 231,000,000 $ 367,000,000